Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glut1 Deficiency Syndrome (Glut1DS): State of the art in 2020 and recommendations of the international Glut1DS study group
Joerg Klepper, Cigdem I. Akman, Marisa Armeno, et al.
Epilepsia Open (2020) Vol. 5, Iss. 3, pp. 354-365
Open Access | Times Cited: 203

Showing 1-25 of 203 citing articles:

ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions
Sameer M. Zuberi, Elaine Wirrell, Elissa Yozawitz, et al.
Epilepsia (2022) Vol. 63, Iss. 6, pp. 1349-1397
Open Access | Times Cited: 541
Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?
Suzanne E. Engelen, Alice Robinson, Yasemin-Xiomara Zurke, et al.
Nature Reviews Cardiology (2022) Vol. 19, Iss. 8, pp. 522-542
Open Access | Times Cited: 260
Brain energy metabolism: A roadmap for future research
Caroline Rae, Joseph A. Baur, Karin Borges, et al.
Journal of Neurochemistry (2024) Vol. 168, Iss. 5, pp. 910-954
Open Access | Times Cited: 35
Clinical Management of Drug Resistant Epilepsy: A Review on Current Strategies
Déborah Guery, Sylvain Rheims
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 2229-2242
Open Access | Times Cited: 77
Current practice in diagnostic genetic testing of the epilepsies
Ilona Krey, Konrad Platzer, Alina Esterhuizen, et al.
Epileptic Disorders (2022) Vol. 24, Iss. 5, pp. 765-786
Open Access | Times Cited: 67
Migraine, Brain Glucose Metabolism and the “Neuroenergetic” Hypothesis: A Scoping Review
Lorenzo Del Moro, Eugenia Rota, Elenamaria Pirovano, et al.
Journal of Pain (2022) Vol. 23, Iss. 8, pp. 1294-1317
Open Access | Times Cited: 39
Transporter-Mediated Drug Delivery
Gergely Gyimesi, Matthias A. Hediger
Molecules (2023) Vol. 28, Iss. 3, pp. 1151-1151
Open Access | Times Cited: 34
Transcellular Barriers to Glucose Delivery in the Body
Amira Klip, Katrien De Bock, Philip J. Bilan, et al.
Annual Review of Physiology (2024) Vol. 86, Iss. 1, pp. 149-173
Open Access | Times Cited: 10
Glucose Transporter 1 Deficiency Impairs Glucose Metabolism and Barrier Induction in Human Induced Pluripotent Stem Cell‐Derived Astrocytes
Iqra Pervaiz, Yash Mehta, Abraham Al‐Ahmad
Journal of Cellular Physiology (2025) Vol. 240, Iss. 1
Closed Access | Times Cited: 1
Clinical Efficacy and Safety of the Ketogenic Diet in Patients with Genetic Confirmation of Drug-Resistant Epilepsy
Jihoon Na, Hyun Joo Lee, Young‐Mock Lee
Nutrients (2025) Vol. 17, Iss. 6, pp. 979-979
Open Access | Times Cited: 1
Energy metabolism in childhood neurodevelopmental disorders
Alfonso Oyarzábal, Uliana Musokhranova, Barros LF, et al.
EBioMedicine (2021) Vol. 69, pp. 103474-103474
Open Access | Times Cited: 51
The role of SLC transporters for brain health and disease
Yen Nguyen, Hoa Thi Thuy Ha, Tra H. Nguyen, et al.
Cellular and Molecular Life Sciences (2021) Vol. 79, Iss. 1
Open Access | Times Cited: 48
Lactobacillus casei Zhang exerts anti-obesity effect to obese glut1 and gut-specific-glut1 knockout mice via gut microbiota modulation mediated different metagenomic pathways
Qiuwen He, Yong Zhang, Da Ma, et al.
European Journal of Nutrition (2022) Vol. 61, Iss. 4, pp. 2003-2014
Closed Access | Times Cited: 37
Ketogenic diet administration to mice after a high-fat-diet regimen promotes weight loss, glycemic normalization and induces adaptations of ketogenic pathways in liver and kidney
Souad Nasser, Thomas Solé, Nathalie Véga, et al.
Molecular Metabolism (2022) Vol. 65, pp. 101578-101578
Open Access | Times Cited: 35
Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
Haosheng Zheng, Guojie Long, Yuzhen Zheng, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5344-5344
Open Access | Times Cited: 29
Ketogenic diet for epilepsy and obesity: Is it the same?
Anna Tagliabue, Marisa Armeno, Kirsten A. Berk, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 34, Iss. 3, pp. 581-589
Open Access | Times Cited: 8
International Recommendations for the Management of Adults Treated With Ketogenic Diet Therapies
Mackenzie C. Cervenka, Susan M. Wood, Manny Bagary, et al.
Neurology Clinical Practice (2020) Vol. 11, Iss. 5, pp. 385-397
Open Access | Times Cited: 50
Metabolic Control of Epilepsy: A Promising Therapeutic Target for Epilepsy
Yanqing Fei, Ruting Shi, Zhi Song, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 45
A Review of Targeted Therapies for Monogenic Epilepsy Syndromes
Vincent Zimmern, Berge A. Minassian, Christian Korff
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 27
Newborn screening for neurodevelopmental diseases: Are we there yet?
Wendy K. Chung, Jonathan S. Berg, Jeffrey R. Botkin, et al.
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 2, pp. 222-230
Open Access | Times Cited: 23
Genetic Testing in Children with Developmental and Epileptic Encephalopathies: A Review of Advances in Epilepsy Genomics
Yu‐Tzu Chang, Syuan‐Yu Hong, Wei‐De Lin, et al.
Children (2023) Vol. 10, Iss. 3, pp. 556-556
Open Access | Times Cited: 16
Neurodevelopment Is Dependent on Maternal Diet: Placenta and Brain Glucose Transporters GLUT1 and GLUT3
Tomoko Daida, Bo‐Chul Shin, Carlos Cepeda, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2363-2363
Open Access | Times Cited: 6
Treatable inherited metabolic epilepsies
Itay Tokatly Latzer, Phillip L. Pearl
Epilepsy & Behavior (2024) Vol. 151, pp. 109621-109621
Closed Access | Times Cited: 5
Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 Study
Valentina De Giorgis, Kailash P. Bhatia, Odile Boespflug‐Tanguy, et al.
Movement Disorders (2024) Vol. 39, Iss. 8, pp. 1386-1396
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top